The levels of hypoxia- and angiogenesis-related regulators and matrix metalloproteinase 9 activity in tear fluid of patients with non-penetrating ocular traumas

Authors

  • I.V. Gavrylyak Bogomolets National Medical University, T. Shevchenko blvd., 13, Kyiv, 01601, Ukraine
  • N.K. Greben Bogomolets National Medical University, T. Shevchenko blvd., 13, Kyiv, 01601, Ukraine
  • V.L. Bilous Palladin Institute of Biochemistry of NAS of Ukraine, Leontovicha str., 9, Kyiv, 01054, Ukraine
  • V.V. Korsa Palladin Institute of Biochemistry of NAS of Ukraine, Leontovicha str., 9, Kyiv, 01054, Ukraine
  • D.G. Zhaboiedov Bogomolets National Medical University, T. Shevchenko blvd., 13, Kyiv, 01601, Ukraine
  • C.A. Ağca Bingol University, Selahaddin-i Eyyübi Mah, Üniversite Cad No. 1, Bingol, 12000, Turkey
  • A.O. Tykhomyrov Palladin Institute of Biochemistry of NAS of Ukraine, Leontovicha str., 9, Kyiv, 01054, Ukraine

DOI:

https://doi.org/10.26641/2307-0404.2022.4.271217

Keywords:

tear fluid, corneal trauma, D-dimer, HIF-1α, angiostatins, matrix metalloproteinase 9

Abstract

This article was focused on the evaluation of protein biomarkers related to thrombosis, hypoxia, angiogenesis, and tissue remodeling in tear fluid of patients with non-penetrating corneal trauma. 32 patients with non-penetrating corneal injures were enrolled in the study, the control group consisted of 15 healthy patients. Samples of tear fluid were collected from the patients and control volunteers with the use of a disposable end micropipette. Protein levels of D-dimer, hypoxia-inducible factor 1α (HIF-1α), angiostatins, and matrix metalloproteinase 9 (MMP-9) in tear fluids were determined by western blot analysis. Proteolytic activity values of MMP-9 were measured by gelatin zymography. Results of western blot and zymography assay were calculated by densitometry analysis and expressed as arbitrary units. Significant increase of D-dimer and HIF-1α levels in tear fluid of patients with injured cornea by 7.3 (p<0.05) and 56 (p<0.001) folds, respectively was shown, compared with control, indicating thrombotic events and hypoxia condition to be involved in pathogenesis of ocular trauma. Dramatically elevated levels/activity of MMP-9 enzyme (by 105 folds vs. control, p<0.001) suggests intense tissue remodeling and degradation of extracellular matrix in the damaged cornea. Up-regulation of angiostatin level, products of proteolytical cleavage of plasminogen, in tear fluid collected from patients with traumatic eye in comparison with healthy volunteers (by 7.3 folds, p<0.05), could represent an adaptive mechanism, which counteracts excessive hypoxia-induced neovascularization of injured cornea. It is summarized that there was a strong association between elevation of D-dimer, HIF-1α, angiostatins, and MMP-9 levels suggesting thrombosis- and hypoxia-mediated mechanisms triggering wound healing of injured cornea. The findings of this study are novel and provide a basis for further investigations of the reparation mechanisms during non-penetrating ocular trauma. Studied proteins of tear fluid can serve as relevant biomarkers of corneal wound healing and are appropriate for diagnostic and prognostic purposes.

References

Ljubimov AV, Saghizadeh M. Progress in corneal wound healing. Prog Retin Eye Res. 2015 Nov; 49:17-45. doi: https://doi.org/10.1016/j.preteyeres.2015.07.002

Willmann D, Fu L, Melanson SW. Corneal Injury. 2022 May 2. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan. PMID: 29083785.

Jones G, Lee TJ, Glass J, Rountree G, Ulrich L, Estes A, et al. Comparison of different mass spectrometry workflows for the proteomic analysis of tear fluid. Int J Mol Sci. 2022 Feb 19;23(4):2307. doi: https://doi.org/10.3390/ijms23042307

Pang K, Lennikov A, Yang M. Hypoxia adapta-tion in the cornea: current animal models and underlying mecha¬nisms. Animal Model Exp Med. 2021 Nov 28;4(4):300-10. doi: https://doi.org/10.1002/ame2.12192

Voelter K, Tappeiner C, Riond B, Nuss K, Bruetsch D, Pot SA. Evaluation of D-dimer levels in aqueous humor of rabbit eyes with and without induced intraocular fibrin and fibrinolytic treatment. Vet Ophthalmol. 2020 Mar;23(2):212-8. doi: https://doi.org/10.1111/vop.12706

Lee D, Miwa Y, Kunimi H, Ibuki M, Shoda C, Nakai A, Kurihara T. HIF inhibition therapy in ocular diseases. Keio J Med. 2022 Mar 25;71(1):1-12. doi: https://doi.org/10.2302/kjm.2021-0004-IR

Wolf M, Clay SM, Oldenburg CE, Rose-Nussbaumer J, Hwang DG, Chan MF. Overexpression of MMPs in corneas requiring penetrating and deep anterior lamellar keratoplasty. Invest Ophthalmol Vis Sci. 2019 Apr 1;60(5):1734-47. doi: https://doi.org/10.1167/iovs.18-25961

Singh A, Maurya OP, Jagannadhan MV, Patel A. Matrix metalloproteinases (MMP-2 and MMP-9) activity in corneal ulcer and ocular surface disorders determined by gelatin zymography. J Ocul Biol Dis Infor. 2012 Dec 29;5(2):31-5. doi: https://doi.org/10.1007/s12177-012-9096-8

Waszczykowska A, Podgórski M, Waszczykowski M, Gerlicz-Kowalczuk Z, Jurowski P. Matrix metal-loproteinases MMP-2 and MMP-9, their inhibitors TIMP-1 and TIMP-2, vascular endothelial growth factor and sVEGFR-2 as predictive markers of ischemic retinopathy in patients with systemic sclerosis-case series report. Int J Mol Sci. 2020 Nov 18;21(22):8703. doi: https://doi.org/10.3390/ijms21228703

Petrenko OM, Tykhomyrov AA. Levels of angiogenic regulators and MMP-2, -9 activities in Martorell ulcer: a case report. Ukr Biochem J. 2019 Jan-Feb;91(1):100-7. doi: https://doi.org/10.15407/ubj91.01.100

Stoscheck CM. Quantitation of protein. Methods Enzymol. 1990;182:50-68. doi: https://doi.org/10.1016/0076-6879(90)82008-P

Taylor SC, Posch A. The design of a quantitative western blot experiment. Biomed Res Int. 2014;2014:361590. doi: https://doi.org/10.1155/2014/361590

Ranganathan P. An introduction to statistics: choosing the correct statistical test. Indian J Crit Care Med. 2021 May;25(Suppl 2):S184-S186. doi: https://doi.org/10.5005/jp-journals-10071-23815

Fu R, Klinngam W, Heur M, Edman MC, Hamm-Alvarez SF. Tear proteases and protease inhi¬bitors: potential biomarkers and disease drivers in ocular surface disease. Eye Contact Lens. 2020 Mar;46(Suppl 2):S70-S83. doi: https://doi.org/10.1097/ICL.0000000000000641

Coppini LP, Visniauskas B, Costa EF, Filho MN, Rodrigues EB, Chagas JR, et al. Corneal angiogenesis modulation by cysteine cathepsins: In vitro and in vivo studies. Exp Eye Res. 2015 May;134:39-46. doi: https://doi.org/10.1016/j.exer.2015.03.012

Hagan S, Martin E, Enríquez-de-Salamanca A. Tear fluid biomarkers in ocular and systemic disease: potential use for predictive, preventive and personalised medicine. EPMA J. 2016 Jul 13;7(1):15. doi: https://doi.org/10.1186/s13167-016-0065-3

Zhan X, Li J, Guo Y, Golubnitschaja O. Mass spectrometry analysis of human tear fluid biomarkers specific for ocular and systemic diseases in the context of 3P medicine. EPMA J. 2021 Dec 3;12(4):449-75. doi: https://doi.org/10.1007/s13167-021-00265-y

Bukowiecki A, Hos D, Cursiefen C, Eming SA. Wound-healing studies in cornea and skin: parallels, differences and opportunities. Int J Mol Sci. 2017 Jun 12;18(6):1257. doi: https://doi.org/10.3390/ijms18061257

Nishida T, Kojima T, Kataoka T, Isogai N, Yoshida Y, Nakamura T. Comparison of corneal biome-chanical properties and corneal tomography between customized and accelerated corneal crosslinking in eyes with keratoconus. Cornea. 2021 Jul 1;40(7):851-8. doi: https://doi.org/10.1097/ICO.0000000000002572

Sugioka K, Fukuda K, Nishida T, Kusaka S. The fibrinolytic system in the cornea: a key regulator of corneal wound healing and biological defense. Exp Eye Res. 2021 Mar;204:108459. Epub 2021 Jan 23. doi: https://doi.org/10.1016/j.exer.2021.108459

Bitirgen G, Korkmaz C, Zamani A, Ozkagnici A, Zengin N, Ponirakis G, Malik RA. Corneal confocal microscopy identifies corneal nerve fibre loss and increased dendritic cells in patients with long COVID. Br J Ophthalmol. 2021 Jul 26:bjophthalmol-2021-319450. doi: https://doi.org/10.1136/bjophthalmol-2021-319450

Hashimoto T, Shibasaki F. Hypoxia-inducible factor as an angiogenic master switch. Front Pediatr. 2015 Apr 24;3:33. doi: https://doi.org/10.3389/fped.2015.00033

Peral A, Mateo J, Domínguez-Godínez CO, Carra¬cedo G, Gómez JA, Crooke A, Pintor J. Therapeutic potential of topical administration of siRNAs against HIF-1α for corneal neovascularization. Exp Eye Res. 2022 Jun;219:109036. doi: https://doi.org/10.1016/j.exer.2022.109036

Lee YH, Bang SP, Shim KY, Son MJ, Kim H, Jun JH. Association of tear matrix metalloproteinase 9 immu¬noassay with signs and symptoms of dry eye disease: a cross-sectional study using qualitative, semiquantitative, and quantitative strategies. PLoS One. 2021 Oct 18;16(10):e0258203. doi: https://doi.org/10.1371/journal.pone.0258203

Bilous VL, Kapustianenko LG, Tykhomyrov AA. Production and application of angiostatins for the treatment of ocular neovascular diseases. Biotech Acta. 2021;14(1):5-24. doi: https://doi.org/10.15.407/biotech14.01.005

Sack RA, Beaton AR, Sathe S. Diurnal variations in angiostatin in human tear fluid: a possible role in prevention of corneal neovascularization. Curr Eye Res. 1999 Mar;18(3):186-93. doi: https://doi.org/10.1076/ceyr.18.3.186.5367

Wu P, Duan F, Luo C, et al. Characteristics of ocular findings of patients with coronavirus disease 2019 (COVID-19) in Hubei Province, China. JAMA Ophthalmol 2020;138:575-8. doi: https://doi.org/10.1001/jamaophthalmol.2020.1291

Jiang L, Yang Y, Gandhewar J. Bilateral corneal endothelial failure following COVID-19 pneumonia. BMJ Case Rep. 2021 Sep 20;14(9):e242702. doi: https://doi.org/10.1136/bcr-2021-242702

Downloads

Published

2022-12-29

How to Cite

1.
Gavrylyak I, Greben N, Bilous V, Korsa V, Zhaboiedov D, Ağca C, Tykhomyrov A. The levels of hypoxia- and angiogenesis-related regulators and matrix metalloproteinase 9 activity in tear fluid of patients with non-penetrating ocular traumas. Med. perspekt. [Internet]. 2022Dec.29 [cited 2024Apr.14];27(4):168-76. Available from: https://journals.uran.ua/index.php/2307-0404/article/view/271217

Issue

Section

CLINICAL MEDICINE